USADA published a comprehensive 200-page Reasoned Decision on October 10, 2012, documenting Armstrong's doping programme with reference to physical evidence, financial records, and teammate testimony. Armstrong chose not to contest the USADA proceedings.

Approximately 26 current and former teammates and associates submitted affidavits to USADA. These included George Hincapie — Armstrong's most loyal domestique, who had never previously spoken against him — as well as Tyler Hamilton, Floyd Landis, Christian Vande Velde, and Levi Leipheimer.

In a two-part interview broadcast on OWN on January 17 and 18, 2013, Armstrong confirmed doping with EPO, blood transfusions, testosterone, and cortisone across his Tour de France victories. He stated he did not believe he could have won the titles without doping.

Former teammate Floyd Landis filed a whistleblower suit under the False Claims Act alleging the US Postal Service was defrauded by sponsoring a team engaged in prohibited conduct. Armstrong settled with the Department of Justice for $5 million in 2018.

Armstrong had previously sued the Sunday Times for libel over doping allegations. Following his confession, he settled with the Times for a sum reported at approximately £500,000 covering legal costs and damages — reversing his earlier libel position.

Armstrong received a lifetime competitive ban from USADA and the UCI accepted the findings. His seven Tour de France titles from 1999 to 2005 were vacated. The UCI decided not to reassign the titles given the widespread doping environment of the era.

Dr. Michele Ferrari was a central figure in designing and administering Armstrong's doping programme. Ferrari had long been associated with EPO use in cycling and was banned by the Italian Olympic Committee in 2002; he continued his relationship with Armstrong after the ban.

Before his 2013 confession Armstrong had denied doping in depositions, interviews, and public statements for more than a decade, and pursued aggressive legal action against journalists and former teammates who alleged he doped. The sustained denial makes the eventual admission the more significant.

Erythropoietin was not directly testable in urine until 2000, and blood-passport methodology was not adopted by UCI until 2008. Armstrong's Tour victories from 1999 to 2005 occurred precisely in the window when EPO detection was most limited. Pre-2000 samples later retested were flagged but not sanctionable under anti-doping rules of the time. The testing gap was a genuine scientific limitation — not evidence that regulators knowingly concealed positive results on Armstrong's behalf.

The USADA reasoned decision identified widespread EPO and transfusion doping throughout the peloton during Armstrong's era. Multiple Tour podium finishers — Ullrich, Pantani, Zulle, Vinokourov — were subsequently linked to doping programs. This context does not exonerate Armstrong but significantly limits the framing of a uniquely protected conspiracy. A sport with near-universal doping at the elite level is a systemic-culture failure, not evidence that Armstrong alone benefited from official protection unavailable to his competitors.

USADA published a comprehensive 200-page Reasoned Decision on October 10, 2012, documenting Armstrong's doping programme with reference to physical evidence, financial records, and teammate testimony. Armstrong chose not to contest the USADA proceedings.

Approximately 26 current and former teammates and associates submitted affidavits to USADA. These included George Hincapie — Armstrong's most loyal domestique, who had never previously spoken against him — as well as Tyler Hamilton, Floyd Landis, Christian Vande Velde, and Levi Leipheimer.

In a two-part interview broadcast on OWN on January 17 and 18, 2013, Armstrong confirmed doping with EPO, blood transfusions, testosterone, and cortisone across his Tour de France victories. He stated he did not believe he could have won the titles without doping.

Former teammate Floyd Landis filed a whistleblower suit under the False Claims Act alleging the US Postal Service was defrauded by sponsoring a team engaged in prohibited conduct. Armstrong settled with the Department of Justice for $5 million in 2018.

Armstrong had previously sued the Sunday Times for libel over doping allegations. Following his confession, he settled with the Times for a sum reported at approximately £500,000 covering legal costs and damages — reversing his earlier libel position.

Armstrong received a lifetime competitive ban from USADA and the UCI accepted the findings. His seven Tour de France titles from 1999 to 2005 were vacated. The UCI decided not to reassign the titles given the widespread doping environment of the era.

Dr. Michele Ferrari was a central figure in designing and administering Armstrong's doping programme. Ferrari had long been associated with EPO use in cycling and was banned by the Italian Olympic Committee in 2002; he continued his relationship with Armstrong after the ban.

Before his 2013 confession Armstrong had denied doping in depositions, interviews, and public statements for more than a decade, and pursued aggressive legal action against journalists and former teammates who alleged he doped. The sustained denial makes the eventual admission the more significant.

Erythropoietin was not directly testable in urine until 2000, and blood-passport methodology was not adopted by UCI until 2008. Armstrong's Tour victories from 1999 to 2005 occurred precisely in the window when EPO detection was most limited. Pre-2000 samples later retested were flagged but not sanctionable under anti-doping rules of the time. The testing gap was a genuine scientific limitation — not evidence that regulators knowingly concealed positive results on Armstrong's behalf.

The USADA reasoned decision identified widespread EPO and transfusion doping throughout the peloton during Armstrong's era. Multiple Tour podium finishers — Ullrich, Pantani, Zulle, Vinokourov — were subsequently linked to doping programs. This context does not exonerate Armstrong but significantly limits the framing of a uniquely protected conspiracy. A sport with near-universal doping at the elite level is a systemic-culture failure, not evidence that Armstrong alone benefited from official protection unavailable to his competitors.